SCHEMBL4518980

SCHEMBL4518980

COCC12CN(S(=O)(=O)c3cc4cc(Cl)ccc4n3S(=O)(=O)c3ccccc3)CC(=O)N1CC1(CCN(Cc3ccccc3)CC1)N2C(C)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 1/20 0.39
ALDH1A1 P00352 4/20 0.37
KDM4E B2RXH2 1/20 0.37
PPARG P37231 5/20 0.35
PPARA Q07869 5/20 0.35
PPARD Q03181 3/20 0.35
LMNA P02545 3/20 0.34
TSHR P16473 2/20 0.34
MAPK1 P28482 1/20 0.34
USP2 O75604 2/20 0.34
CYP2D6 P10635 2/20 0.34
TRPV4 Q9HBA0 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
GAA P10253 2/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4522105 0.90 F10 (0.46) F10ALDH1A1KDM4EPPARGPPARA
SCHEMBL4518984 0.88 F10 (0.42) F10ALDH1A1KDM4EPPARGPPARA
SCHEMBL4528692 0.82 F10 (0.46) F10ALDH1A1PPARGPPARAPPARD
SCHEMBL4528484 0.82 F10 (0.43) F10ALDH1A1KDM4EPPARGPPARA
SCHEMBL4524982 0.81 F10 (0.44) F10ALDH1A1KDM4EPPARGPPARA
SCHEMBL4518134 0.81 F10 (0.43) F10PPARGPPARAPPARD
SCHEMBL4527381 0.81 F10 (0.45) F10ALDH1A1KDM4EPPARGPPARA
SCHEMBL4534417 0.80 F10 (0.45) F10ALDH1A1KDM4EPPARGPPARA
SCHEMBL4516479 0.80 ALDH1A1 (0.39) ALDH1A1KDM4EPPARGPPARAPPARD
SCHEMBL4528341 0.79 F10 (0.39) F10PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090076015-A1 Tricyclic Spiro Compound Comprising Acyl Group Bound to Nitrogen Atom in the Ring MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2009-03-19 US disclosed
EP-1864984-A1 TRICYCLIC SPIRO COMPOUND COMPRISING ACYL GROUP BOUND TO NITROGEN ATOM IN THE RING MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2007-12-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076015-A1 Tricyclic Spiro Compound Comprising Acyl Group Bound to Nitrogen Atom in the Ring KCNH1, SCN1A, SCN10A F10 157/4885ALDH1A1 2791/4885KDM4E 2297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.